10 Best International Stocks To Buy For 2015


The self-regulatory organization overseeing municipal bonds introduced on Monday a new way for investors to analyze prices in the often opaque market.

The Municipal Securities Rulemaking Board launched a tool on its Electronic Municipal Markets Access website designed to enable users to more easily find and compare prices for municipal securities with similar characteristics, such as geography, interest rates and maturity.

The tool will provide side-by-side comparisons of price and yield of up to five bonds at a time. It also can produce a graph of a bond’s historical pricing.

10 Best International Stocks To Buy For 2015: Insulet Corporation(PODD)


Insulet Corporation, a medical device company, engages in the development, manufacture, and marketing of insulin infusion systems for people with insulin-dependent diabetes in the United States. The company offers OmniPod Insulin Management System (OmniPod System), which consists of the OmniPod disposable insulin infusion device and the handheld wireless personal diabetes manager to provide diabetes management solution for people with insulin-dependent diabetes. It is also involved in the distribution of durable medical equipment, including blood glucose testing supplies, insulin pumps, pump supplies, pharmaceuticals, and other products for the management and treatment of diabetes. The company sells its OmniPod System directly to patients through referrals from healthcare professionals and through patient leads, as well as through third-party distributors; and delivers durable medical equipment to endocrinologists, insurers, and clients. Insulet Corporation was founded in 2000 and is headquartered in Bedford, Massachusetts.


Advisors’ Opinion:

  • [By Rich Smith]

    This series, brought to you by Yahoo! Finance, looks at which upgrades and downgrades make sense, and which ones investors should act on. Today, our headlines feature a pair of downgrades for document storage company Iron Mountain (NYSE: IRM  ) and insulin treatments-equipment maker Insulet (NASDAQ: PODD  ) . But the headlines aren’t all bad, so before we break the bad news to you, let’s start off on a bright note about…

  • [By James Brumley]

    And just for the record, theme-based buyout speculation doesn’t improve your chances of picking an acquisition target. Back in 2012 after Bristol-Myers Squibb (BMY) bought Amylin for control of its diabetes pipeline following the purchase of Neighborhood Diabetes by Insulet (PODD), pundits were sure it would spark a wave of other diabetes-driven acquisitions. Those other M&A candidates began getting bid up, but as it turns out, no more meaningful buyouts materialized in the diabetes space.

10 Best International Stocks To Buy For 2015: Ship Finance International Limited(SFL)


Ship Finance International Limited, through its subsidiaries, engages in the ownership and operation of vessels and offshore related assets in Bermuda, Cyprus, Malta, Liberia, Norway, the United States, Singapore, the United Kingdom, and the Marshall Islands. The company also involves in the charter, purchase, and sale of assets. As of March 22, 2011, it owned 29 oil tankers, 8 oil/bulk/ore carriers, 3 dry bulk carriers, 9 container vessels, 2 jack-up drilling rigs, 3 ultra-deepwater drilling units, 6 offshore supply vessels, and 2 chemical tankers. The company offers its services to various sectors of shipping and offshore industry, including oil transportation, drybulk shipments, chemical transportation, container transportation, drilling rigs, and offshore supply vessels. Ship Finance International Limited was founded in 2003 and is based in Hamilton, Bermuda.


Advisors’ Opinion:

  • [By Ben Levisohn]

    While [Seadrill] will continue to lean on [Seadrill Partners (SDLP)] and potentially [Ship Finance International (SFL)] to meet its funding requirements, a lot has to break right for [Seadrill] to meet these funding requirements.

  • [By James Brumley]

    But they’re also potent. Not only do they contain the possibility for significant capital appreciation, but they also offer plenty as far as dividends are concerned. In fact, of the following four small caps, the weakest dividend yield is still a very healthy 8%.


    Ship Finance International Limited (SFL)

    SFL Dividend Yield: 9.1%

  • [By John Buckingham, Chief Investment Officer, Al Frank Asset Management, Inc. (AFAM)]

    Ship Finance International (SFL) primarily engages in the transportation of crude oil and oil products, dry bulk, and containerized cargos, and in offshore drilling and related activities.

10 Best International Stocks To Buy For 2015: United Insurance Holdings Corp (UIHC)

United Insurance Holdings Corp. (UIHC), incorporated on May 22, 2007, is a holding company for United Property and Casualty Insurance Company and its affiliated companies. Its business is conducted principally through four wholly-owned subsidiaries, including United Property and Casualty Insurance Company (UPC), which writes insurance policies; United Insurance Management, L.C. (UIM), the managing general agent that manages substantially all aspects of UPC’s business, Skyway Claims Services, LLC (SCS), a claims adjusting company that provides services to UPC; and UPC Re. UPC Re provides reinsurance protection to UPC.


The Company offers standardized policies for a range of exposures, and its policies include coverage options for standard single-family homeowners, tenants (renters), and condominium unit owners. It also writes flood policies. The Company has authorization to write a commercial line of business in Florida that includes auto and multi-peril coverag e but the Company does not write commercial business. The Company offers standardized policies for a broad range of exposures, and its policies include coverage options for standard single-family homeowners, tenants (renters), and condominium unit owners.


The Company competes with Citizens Property Insurance Corporation, State Farm Florida Insurance Company, Universal Property & Casualty Insurance Company, St. Johns Insurance Company, Inc., United Services Automobile Association, American Coastal Insurance Company, Florida Peninsula Insurance Company, Security First Insurance Company, Homeowners Choice Property & Casualty Insurance Company, Inc., United Property & Casualty Insurance Company, Tower Hill Prime Insurance Company, Federal Insurance Company, USAA Casualty Insurance Company, Castle Key Insurance Company, American Integrity Insurance Company of Florida, Tower Hill Signature Insurance Company, ASI Assurance Corp., Tower Hill Preferred Insurance Company, Chartis Property Casualty Company and Universal Insurance C! ompany of North America.


Advisors’ Opinion:

  • [By , Zacks Investment Research]

    United Insurance Holdings Corp (UIHC) is a holding company that focuses primarily on providing homeowners’ insurance in Florida, South Carolina, Massachusetts, Rhode Island and North Carolina. It is headquartered in St. Petersburg, Fla., and has a market cap of $348 million.

  • [By Louis Navellier]

    United Insurance Holdings (UIHC) is a great example of a best of the best stock that should climb the wall of worry this summer. Writing homeowners and flood insurance might not be the most exciting business sin the word but the fundamentals of this company are really exciting.

10 Best International Stocks To Buy For 2015: Neutra Corp (NTRR)


Neutra Corp. incorporated on January 11, 2011, is a development-stage company. The Company’s business and registered office is located in Sarasota, Florida. The Company’s intended private label products consists of aging, cognitive support, antioxidants/flavonoids, circulatory support, detoxification support, endocrine support, essential fatty acids, gastrointestinal support, immune support, men’s health, minerals, mood/sleep support, multiples, musculoskeletal support, neurological support, proteins/amino acids, vitamins, women’s health and veterinary products. The Company’s product focuses to research and development in a range of areas, such as weight-loss, detox, men’s health, acid-alkali pH balance, anti-aging, sleep disorders, autism, pain management with the use of medical cannabis products, and air space sanitation derived by nutraceutical technology.


The Company focuses to market and sell nutraceutical supplement products to health practi tioners. It focuses direct marketing and sales towards Members of the American Association for Health Freedom (American Association for Health Freedom has merged with Alliance for Natural Health) www.anh-usa.org; American Association of Naturopathic Physicians, www.naturopathic.org; American Association of Oriental Medicine, www.aaom.org, and American College for Advancement in Medicine, www.acamnet.org. It also focuses direct marketing and sales towards American Holistic Medical Association, www.holisticmedicine.org; American Dietetic Association, www.eatright.org, and American Herbalist Guild, www.americanherbalistsguild.com.


The Company competes with Thone Research, The Vitamin Company, Nutraceutical International Corporation, Protocol For Life, Medagenics and Standard Process.

Advisors’ Opinion:

  • [By CRWE]

    Today, NTRR surged (+19.45%) up +0.068 at $.420 with 22,114 shares in play thus far (ref. google finance Delayed: 11:17AM EDT July 11, 2013).

    As Neutra Corp. works to deliver new innovations to the U.S. medical marijuana industry, the market for those innovations continues to grow. Last week, lawmakers passed a bill to make New Hampshire the 19th state to approve medical marijuana (MMJ) prescriptions for patients with chronic or terminal illnesses.


    The legislation will make New Hampshire the 19th state to legalize MMJ, in addition to the District of Columbia. Five more states have legislation pending to legalize prescriptions, according to ProCon.org.

  • [By CRWE]

    Today, NTRR has shed (-5.26%) down -0.020 at $.360 with 14,150 shares in play thus far (ref. google finance Delayed: 10:46AM EDT July 3, 2013), but don’t let this get you down.

    Neutra Corp. through a key new partnership with an innovative cannabis delivery systems provider in the medical marijuana industry, is poised to make an impact in the lucrative $52 billion pain management market.


    With partner Field of View Technologies, LLC, exploring new technology in cannabis delivery systems, NTRR is ready to provide much-needed smokeless delivery systems to those most in need: patients forced to live with debilitating pain.

    A recent study by Columbia University found that smoke-free cannabinoid medication was effective in treating pain. Smokeless delivery systems can be administered orally, by injection or topically, giving the patient the choice of treatment method as NTRR and Field of View set the pace in the potentially lucrative pain management market.

10 Best International Stocks To Buy For 2015: Neurocrine Biosciences Inc.(NBIX)

Neurocrine Biosciences, Inc. engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. It develops drugs for endometriosis, stress-related disorders, pain, tardive dyskinesia, uterine fibroids, diabetes, insomnia, and other neurological and endocrine-related diseases and disorders. The company?s products in clinical development include Elagolix, a Phase II drug for endometriosis; Vesicular Monoamine Transporter 2 Inhibitor (VMAT2), a Phase II drug for movement disorders; CRF2 Peptide Agonist, a Phase II drug for cardiovascular diseases; CRF1 Antagonist, a Phase II drug for stress-related disorders; and Elagolix, a Phase II drug for uterine fibroids. Its research programs comprise G Protein-Coupled Receptor 119 (GPR119) for type II diabetes; VMAT2 for schizophrenia; GnRH Antagonists for men?s and women?s health, and oncology; Antiepileptic Drugs for epilepsy, ess ential tremor, and pain; and G Protein-Coupled Receptors for other conditions. The company has collaborations with GlaxoSmithKline to develop and commercialize CRF antagonists for psychiatric, neurological, and gastrointestinal diseases; Dainippon Sumitomo Pharma Co. Ltd. to develop and commercialize Indiplon in Japan; Abbott International Luxembourg S.